Virtus LifeSci Biotech Products ETF Rating $57.83 -0.35 (-0.60%) Closing price 04:10 PM EasternExtended Trading$57.88 +0.05 (+0.09%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.74Holdings in BBP have an aggregate rating of Moderate Buy based on 658 analyst ratings issued in the past year covering 50 companies (89.8% of the portfolio).BBP Aggregate Price Target$57.83High Prediction$57.83Average Prediction$57.83Low Prediction$57.83Holdings in BBP have an aggregate price target of $57.83 and a range of $57.83 to $57.83 covering 50 companies (89.8% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.51%SAGESage Therapeutics$7.17-1.8%3.8444 of 5 stars2.00$8.81 22.9%19Earnings ReportAnalyst UpgradeAnalyst RevisionNews Coverage2.43%ONCBeigene$254.16-0.6%2.6709 of 5 stars3.00$318.88 25.5%62.36%ASNDAscendis Pharma A/S$170.74-0.8%3.2507 of 5 stars3.00$216.07 26.5%15Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up2.31%BBIOBridgeBio Pharma$38.22-0.9%4.6177 of 5 stars2.92$57.09 49.4%12Earnings ReportAnalyst Revision2.30%TGTXTG Therapeutics$37.68-13.3%3.2692 of 5 stars2.80$40.80 8.3%5Earnings ReportUpcoming EarningsOptions VolumeNews CoveragePositive NewsGap DownHigh Trading Volume2.29%HALOHalozyme Therapeutics$60.62-0.9%4.1092 of 5 stars2.60$62.89 3.7%10Upcoming Earnings2.18%GILDGilead Sciences$102.81-0.8%4.8975 of 5 stars2.78$110.55 7.5%27Positive News2.12%ZLABZai Lab$30.95-0.7%2.3854 of 5 stars2.75$47.37 53.0%4Upcoming Earnings2.09%AXSMAxsome Therapeutics$116.49+3.8%4.8341 of 5 stars3.00$169.87 45.8%16Earnings ReportShort Interest ↓Analyst RevisionNews CoveragePositive News2.07%RYTMRhythm Pharmaceuticals$64.41+0.6%3.7562 of 5 stars3.00$74.92 16.3%13Upcoming EarningsPositive News2.01%ADMAADMA Biologics$23.71+0.8%1.3748 of 5 stars3.25$22.50 -5.1%4Upcoming Earnings1.96%VRTXVertex Pharmaceuticals$500.19-0.2%3.9332 of 5 stars2.64$514.91 2.9%25News CoveragePositive News1.94%PTCTPTC Therapeutics$40.65-18.6%3.8712 of 5 stars2.53$63.92 57.3%15Upcoming EarningsNews CoveragePositive NewsGap DownHigh Trading Volume1.93%EXELExelixis$39.84+0.6%3.9548 of 5 stars2.47$37.59 -5.7%19Short Interest ↑Positive News1.91%AMGNAmgen$280.06-0.4%4.5276 of 5 stars2.41$308.18 10.0%22Earnings ReportAnalyst ForecastAnalyst RevisionPositive News1.90%KNSAKiniksa Pharmaceuticals$27.78+0.5%2.5914 of 5 stars3.00$38.80 39.7%5Earnings ReportAnalyst Revision1.89%BCRXBioCryst Pharmaceuticals$11.03+23.5%4.4757 of 5 stars2.88$16.13 46.2%8Earnings ReportOptions VolumeNews CoverageGap UpHigh Trading Volume1.87%MDGLMadrigal Pharmaceuticals$306.38-2.9%4.5888 of 5 stars2.90$416.33 35.9%10Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionPositive News1.85%IMCRImmunocore$30.63+0.6%3.042 of 5 stars2.45$59.44 94.1%11Upcoming EarningsPositive News1.84%INSMInsmed$72.58+0.4%4.3591 of 5 stars3.00$94.00 29.5%16Upcoming EarningsInsider TradeNews CoveragePositive News1.83%SWTXSpringWorks Therapeutics$46.231.8893 of 5 stars2.13$52.57 13.7%8Gap Up1.82%ALNYAlnylam Pharmaceuticals$273.55+5.5%4.0929 of 5 stars2.77$319.17 16.7%26Earnings ReportAnalyst Forecast1.81%TARSTarsus Pharmaceuticals$48.00+1.4%3.0212 of 5 stars3.00$66.33 38.2%7Earnings ReportUpcoming EarningsAnalyst ForecastNews CoveragePositive News1.78%KRYSKrystal Biotech$162.29-2.3%4.9206 of 5 stars3.00$222.71 37.2%8Upcoming EarningsAnalyst Revision1.77%TBPHTheravance Biopharma$10.29-0.8%1.1445 of 5 stars2.25$11.33 10.1%4Upcoming EarningsNews Coverage1.76%LGNDLigand Pharmaceuticals$106.35-2.8%4.3902 of 5 stars3.00$146.43 37.7%7Upcoming Earnings1.74%BPMCBlueprint Medicines$101.83-2.7%1.5303 of 5 stars2.76$127.22 24.9%21Earnings ReportAnalyst ForecastNews Coverage1.74%LEGNLegend Biotech$33.40+0.7%2.6398 of 5 stars2.92$78.82 136.0%12Positive News1.73%MIRMMirum Pharmaceuticals$44.15+1.1%4.2413 of 5 stars3.09$58.20 31.8%11Upcoming EarningsPositive News1.71%HRMYHarmony Biosciences$29.96-1.2%4.86 of 5 stars3.00$52.44 75.0%9Upcoming EarningsNews CoveragePositive News1.69%BMRNBioMarin Pharmaceutical$62.06+0.0%4.8999 of 5 stars2.71$93.45 50.6%24Analyst ForecastAnalyst Revision1.66%ARDXArdelyx$3.73-9.7%4.4926 of 5 stars2.90$10.39 178.5%10Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews CoverageHigh Trading Volume1.61%ROIVRoivant Sciences$11.57+0.8%2.3206 of 5 stars3.00$17.50 51.3%41.61%TVTXTravere Therapeutics$21.41+1.2%2.8792 of 5 stars2.87$31.79 48.5%15Earnings ReportAnalyst ForecastNews Coverage1.61%BNTXBioNTech$101.10-3.7%2.704 of 5 stars2.89$143.44 41.9%18News CoverageGap Up1.59%ACADACADIA Pharmaceuticals$15.14+1.5%4.2516 of 5 stars2.50$23.87 57.6%16Upcoming EarningsAnalyst Revision1.59%CRSPCRISPR Therapeutics$37.62-1.6%2.9537 of 5 stars2.48$73.11 94.3%21Upcoming Earnings1.58%IBRXImmunityBio$2.10-17.3%1.528 of 5 stars3.00$12.19 480.4%5Upcoming EarningsGap DownHigh Trading Volume1.54%DVAXDynavax Technologies$11.26-0.6%4.3699 of 5 stars2.33$20.50 82.1%3Upcoming Earnings1.53%INCYIncyte$62.11-0.7%4.7823 of 5 stars2.17$73.53 18.4%18Earnings ReportAnalyst RevisionPositive News1.52%NBIXNeurocrine Biosciences$109.75+0.1%4.8847 of 5 stars2.86$160.90 46.6%22Earnings ReportOptions Volume1.51%AUPHAurinia Pharmaceuticals$8.26+0.6%2.4101 of 5 stars3.00$11.50 39.2%21.50%UTHRUnited Therapeutics$298.70+1.4%4.988 of 5 stars2.67$392.00 31.2%12Earnings ReportAnalyst DowngradeInsider TradePositive News1.47%IONSIonis Pharmaceuticals$33.65+2.7%4.3656 of 5 stars2.65$56.67 68.4%20Earnings ReportInsider TradePositive News1.45%REGNRegeneron Pharmaceuticals$603.58-0.3%4.8279 of 5 stars2.88$892.60 47.9%26Earnings ReportDividend Announcement1.44%RAREUltragenyx Pharmaceutical$38.87-1.1%4.3558 of 5 stars2.93$92.79 138.7%14Upcoming EarningsShort Interest ↑News CoveragePositive News1.43%BIIBBiogen$121.80-1.4%4.6961 of 5 stars2.38$194.56 59.7%32Earnings ReportAnalyst ForecastAnalyst Revision1.37%AGIOAgios Pharmaceuticals$29.97-0.4%4.2094 of 5 stars2.56$56.00 86.9%9Earnings ReportAnalyst ForecastNews Coverage1.34%LXRXLexicon Pharmaceuticals$0.72+5.8%3.3032 of 5 stars2.40$3.67 409.3%5News CoveragePositive News1.27%NVAXNovavax$6.27-2.2%3.583 of 5 stars2.43$18.00 187.1%7Upcoming Earnings This page (NYSEARCA:BBP) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBP Stock Free BBP Stock Alerts